PT  - JOURNAL ARTICLE
AU  - Blum, Arnon
AU  - Nicolaou, Constantina
AU  - Henghes, Ben
AU  - Lahav, Ofer
TI  - On the anti-correlation between COVID-19 infection rate and natural UV light in the UK
AID  - 10.1101/2020.11.28.20240242
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2020.11.28.20240242
4099  - http://medrxiv.org/content/early/2022/02/21/2020.11.28.20240242.short
4100  - http://medrxiv.org/content/early/2022/02/21/2020.11.28.20240242.full
AB  - While it is well established that the rate of COVID-19 infections can be suppressed by social distancing, environmental effects may also affect it. We consider the hypothesis that natural Ultra-Violet (UV) light is reducing COVID-19 infections by enhancing human immunity through increasing levels of Vitamin-D and Nitric Oxide or by suppressing the virus itself. We focus on the United Kingdom (UK), by examining daily COVID-19 infections (F) and UV Index (UVI) data from 23 March 2020 to 10 March 2021. We find an intriguing empirical anti-correlation between log10(F) and log10(UVI) with a correlation coefficient of −0.934 from 11 May 2020 (when the first UK lockdown ended) to 10 March 2021. The anti-correlation may reflect causation with other factors which are correlated with the UVI. We advocate that UVI should be added as a parameter in modelling the pattern of COVID-19 infections and deaths. We started quantifying such correlations in other countries and regions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBH, OL and CN are supported by the STFC UCL Centre for Doctoral Training in Data Intensive Science (grant number ST/P006736/1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe use publicly available data from JHU on COVID-19 and from TEMIS on UVI.